Watch: A Safe, Accessible Treatment for ME/CFS? The IVO-21 Study
Could IVO-21 Lead to a New ME/CFS Mitochondrial Treatment? In May 2026, Solve selected Dr. Jay H. Chung (National Institutes of Health) as a recipient of our latest ME/CFS Catalyst […]
Day: September 12, 2026